HydroX AI Secures $4 Million Angel Funding Round, Launches Groundbreaking EPASS Platform

HydroX AI, a pioneering AI startup dedicated to advancing safety and security in large language models (LLMs), has announced the successful closure of a $4 million angel funding round. This investment, led by Vitalbridge Capital and Atom Capital, along with prominent AI expert Qi Lu, EVP of Microsoft and former COO of Baidu, will bolster…

Read More
Dan Kemp CEO at Shinobi Therapeutics

Shinobi Therapeutics Receives $59M Grant from Japanese Agency for Medical Research and Development

Shinobi Therapeutics, a trailblazer in immune evasive iPS cell therapies, has been awarded up to $59 million in non-dilutive grant funding by the Japanese Agency for Medical Research and Development (AMED). This significant grant will accelerate the development of Shinobi’s pioneering iPS-T cell therapy, aimed at treating GPC3+ solid tumors. Dr. Yasumichi Hitoshi, Chief of…

Read More

Paradigm Health Secures $78M Series B to Embed Clinical Trials in Global Routine Healthcare

Paradigm Health has raised $78 million in an oversubscribed Series B round as the U.S. technology company accelerates its effort to embed clinical trials directly within routine patient care across the country and abroad. The investment was led by ARCH Venture Partners, joined by new backer DFJ Growth and returning investors including F-Prime, General Catalyst,…

Read More

AttoTude Secures $29 Million in Series A Funding to Transform High-Speed Networking for AI and Data Centers

AttoTude, a pioneering company in high-speed interconnect technology for artificial intelligence and hyperscale data center applications, has announced the successful closure of its $29 million Series A funding round. This latest investment follows an $11 million Seed Round concluded earlier this year. The Series A round saw contributions from notable investors, including Sutter Hill Ventures,…

Read More

Kanvas Biosciences Secures $12.5M to Propel Microbiome-Based Cancer Therapies

Kanvas Biosciences, a pioneering spatial biology company, has announced a significant stride in its mission to revolutionize healthcare with microbiome-based therapies. With an additional $12.5 million in funding co-led by DCVC and Lions Capital LLC, and supported by FemHealth Ventures, Germin8, Ki Tua Fund, and Pangaea Ventures, alongside existing investors, the company’s total funding now…

Read More

ContextSDK Secures $4M Seed Funding to Revolutionize Mobile App Development with Edge AI

In a significant move for the mobile app development sector, ContextSDK has successfully raised $4 million in Seed funding to enhance its innovative use of Edge AI technology. This breakthrough approach aims to automatically interpret user signals collected from smartphones, allowing applications to adapt to the real-world context of their users while prioritizing privacy. Understanding…

Read More

Illuma Labs Secures $9 Million in Series A Funding to Enhance Voice Authentication and Combat Fraud

Illuma Labs, a pioneering force in voice authentication technology for banking institutions, has successfully closed a $9 million Series A funding round. The investment, led by LiveOak Ventures and supported by Forefront Venture Partners, Curql Fund, UsNet, Capital Factory, Connexus, and TDECU, will drive the company’s efforts to develop cutting-edge solutions to tackle fraud, voice…

Read More

Excellergy Raises $70M to Rewrite the Allergy Playbook with Trifunctional Biologics

A new force has entered the allergy‑therapeutics arena. Excellergy has announced a bold $70 million Series A round designed to advance its lead candidates—“trifunctional” Effector Cell Response Inhibitors (ECRIs)—toward clinical proof. The molecules aim to simultaneously strip IgE from bound immune cells, neutralize free IgE, and tamp down the receptor expression that fuels allergic cascades….

Read More

CesiumAstro Soars with $65M Funding to Pioneer Next-Gen Space Communications

CesiumAstro Inc., a trailblazer in space communications technology, has secured a significant milestone in its journey with the closing of a Series B+ funding round, amassing a formidable $65 million. Led by Trousdale Ventures and bolstered by strategic investments from Development Bank of Japan Inc. and Quanta Computer, Inc., among others, this funding round marks…

Read More

Viacurrent Raises Undisclosed Amount from Rockstart and Angel Investor to Transform Employee Financial Wellness

Tallinn-based Viacurrent, a pioneering app focused on employee financial wellness, has secured a strategic investment from Amsterdam’s Rockstart, a prominent early-stage accelerator and venture capital firm. Joining the investment round is angel investor Kristjan N., though the exact funding amount remains undisclosed. Viacurrent, spearheaded by Hendrik Ojamaa, Arnold Veltmann, and Johannes Ööpik, is revolutionizing employee…

Read More